[HTML][HTML] Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
MK Jathal, TM Steele, S Siddiqui, BA Mooso… - British journal of …, 2019 - nature.com
Background Despite overexpression of the ErbB (EGFR/HER2/ErbB3/ErbB4) family in
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
[HTML][HTML] Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
MK Jathal, TM Steele, S Siddiqui, BA Mooso… - British Journal of …, 2019 - ncbi.nlm.nih.gov
Background Despite overexpression of the ErbB (EGFR/HER2/ErbB3/ErbB4) family in
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase.
MK Jathal, TM Steele, S Siddiqui, BA Mooso… - British Journal of …, 2019 - europepmc.org
Background Despite overexpression of the ErbB (EGFR/HER2/ErbB3/ErbB4) family in
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase.
MK Jathal, TM Steele, S Siddiqui, BA Mooso… - British journal of …, 2019 - escholarship.org
BackgroundDespite overexpression of the ErbB (EGFR/HER2/ErbB3/ErbB4) family in
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
MK Jathal, TM Steele, S Siddiqui… - British journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Despite overexpression of the ErbB (EGFR/HER2/ErbB3/ErbB4) family in
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …
castration-resistant prostate cancer (CRPC), some inhibitors of this family, including the dual …